Synapse inhibitors

*Synapse inhibitors* are biologically active compounds that suppress the transmission of excitatory signals in the synaptic cleft, which leads to inhibition or interruption of the functioning of the synapse. As a result, the strength and duration of the synaptic signal decreases. Inhibiting the transmission of excitation to the synapse allows one to reduce hyperreactivity and excessive excitability of neurons.

The main mechanism of action of synaptic inhibitors is their effect on the electrical potential, changing the opening time, permeability and rate of closure of the sodium-potassium channel. This leads to changes in intracellular ion balance and neuronal action potential.

Inhibition of synapses can be caused by various factors, such as a high concentration of sodium ions inside the neuron, increased entry of calcium ions into the presynaptic terminal, changes in pH inside synaptic vesicles, or activation of glutamate receptors. These effects can disrupt the barrier function of synapses between two neurons and increase the strength and duration of the synaptic signal between them.

The greatest role in the development of neurological diseases was played by transmission inhibitors not only in synagogues, but also in the hippocampus. For example, some effects of inhibition have been studied

Inhibition of synaptic transmission

Introductions Pharmacological action: Centrally acting H-cholinergic receptor antagonist; m-cholinoreceptor agonist with parasympathetic effects. Causes dilation of blood vessels in the esophagus of the stomach and heart, without exerting a direct myotropic effect. It has a pronounced central hypotensive effect, peripheral cholinergic (anticholinergic) and central antihistamine effects. Reduces intraocular and blood pressure. Regulates the tone of the myometrium. Strengthens the motility of the gastrointestinal tract and synechization of tissues, increasing their regenerative ability. When taken orally, it quickly disappears from the blood plasma (T1/

Synapse inhibitors are biologically active compounds that interfere with the transmission of excitation at the neuromuscular junction. Because of their similar effects, some inhibitors are used to reduce neuronal transmission and impair it in healthy areas of the brain, which has potential applications in the treatment of diseases associated with increased neural activity. They can also be used as epilepsy management agents, by inhibiting the transmission of electrical signals between groups of neurons in epileptic areas of the brain.

Inhibitors, by binding to synaptic receptors, cause various types of membrane action at several levels of the biological process. These inhibitory effects may include a decrease in the conductance of excitatory synaptic inputs to muscle, such as a decrease in heart rate. Other inhibitors reduce its strength by increasing the threshold of tension required to cause nerve irritation or muscle contraction. Inhibitors may reduce muscle soreness following injury, thereby slowing the process of nerve damage; they also show potential for use in diseases involving high neurological arousal, such as neuropathic pain and generalized seizures. An important aspect of their therapeutic use is their action characteristics and distribution through the circulatory system, allowing the use of several different

Synthases are compounds that form a connection between cells and provide signal transmission between them. A synapse inhibitor is a substance that blocks the transmission of information between cells, which can lead to various effects. These effects can be both positive and negative.

Synapse inhibitors have a wide range of applications. They are used to treat various diseases such as cancer, Alzheimer's disease, depression, schizophrenia and other mental disorders. They are also used in pharmacology to create drugs that help control and treat various diseases. In addition, these compounds can be used in scientific research to study signal transmission processes in the brain.

One example of the use of synapse inhibitors is their use in the treatment of Alzheimer's disease. Alzheimer's disease causes degenerative changes in the brain caused by the loss of nerve cells and disruption of signaling between them.